|
CAPZA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.238600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.342100E-02 |
| Normal-vs-Stage2 |
8.486400E-02 |
| Normal-vs-Stage3 |
4.777900E-02 |
| Normal-vs-Stage4 |
1.993860E-02 |
| Stage1-vs-Stage2 |
9.951000E-01 |
| Stage1-vs-Stage3 |
8.922000E-01 |
| Stage1-vs-Stage4 |
5.665800E-01 |
| Stage2-vs-Stage3 |
9.334400E-01 |
| Stage2-vs-Stage4 |
6.519400E-01 |
| Stage3-vs-Stage4 |
5.485000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.540440E-02 |
| Normal-vs-AfricanAmerican |
3.582000E-01 |
| Normal-vs-Asian |
1.285730E-02 |
| Caucasian-vs-AfricanAmerican |
5.702400E-01 |
| Caucasian-vs-Asian |
4.112600E-01 |
| AfricanAmerican-vs-Asian |
2.670400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.898800E-03 |
| Normal-vs-Female |
2.748200E-02 |
| Male-vs-Female |
1.356010E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.519900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.678040E-02 |
| Normal-vs-Age(61-80Yrs) |
1.916220E-02 |
| Normal-vs-Age(81-100Yrs) |
3.508600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.251000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.768200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.609000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.342200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.288600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.191800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.978600E-01 |
| Classical-VS-Follicular |
8.543200E-03 |
| Classical-VS-Other |
1.138030E-01 |
| Classical-VS-Normal |
1.451210E-01 |
| Tall-VS-Follicular |
5.906200E-02 |
| Tall-VS-Other |
8.684100E-02 |
| Tall-VS-Normal |
5.566600E-01 |
| Follicular-VS-Other |
5.532600E-01 |
| Follicular-VS-Normal |
1.480720E-03 |
| Other-VS-Normal |
2.211600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.236980E-03 |
| Normal-vs-N1 |
5.158200E-03 |
| N0-vs-N1 |
4.462000E-01 |
|
|
